Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SVANELABORATORIET AS
AS
Active
Org 980383172
Huvikveien 14, 3222 Sandefjord
Manufacture of other chemical products n.e.c. · NACE 2059
Est. 1998
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 6,5M
-7% vs 2023
EBITDA margin
53.7%
-18% vs 2023
Equity ratio
92.0%
Financial strength
Net profit 2024
NOK 3,1M
-12% vs 2023
EBITDA — year on year
NOK millions
5M
4M
3M
1M
0M
3M
2020
4M
+33%
2021
4M
0%
2022
4M
0%
2023
4M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 6,5M
-7%
EBITDA
NOK 3,5M
-18%
Net profit
NOK 3,1M
-12%
Total assets
NOK 11,7M
-30%
Equity
NOK 10,7M
-31%
Employees
0
—
Company information
Legal name
SVANELABORATORIET AS
Org number
980383172
Legal form
Aksjeselskap
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
20. oktober 1998
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Contact
Address
Huvikveien 14, 3222 Sandefjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of other chemical products n.e.c.
Companies in Sandefjord
All Norway companies
Revenue
NOK millions
0M
2M
4M
6M
8M
5M
2020
7M
2021
7M
2022
7M
2023
7M
2024
EBITDA
NOK millions
0M
1M
2M
3M
5M
3M
2020
4M
2021
4M
2022
4M
2023
4M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
5 200
6 623
7 048
7 056
6 542
Staff expenses
−0
−0
−0
−0
−0
EBITDA
2 707
4 028
3 653
4 272
3 510
Depreciation & amort.
−23
−29
−29
−29
−29
EBIT
2 684
3 999
3 624
4 242
3 481
Net financials
47
22
63
309
521
Profit before tax
2 731
4 021
3 687
4 551
4 002
Tax
601
885
811
1 001
880
Net profit
2 130
3 137
2 876
3 550
3 122
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
8 174
10 942
13 071
16 765
11 653
Equity
6 038
9 175
12 051
15 601
10 722
Long-term debt
1
0
0
0
0
Short-term debt
2 135
1 767
1 020
1 164
931
Total debt
2 136
1 767
1 020
1 164
931
Financial ratios
5-year trend
EBITDA margin
53.7%
This company
15.8%
Market median
+240% vs market
2020
2024
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
2020
2024
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
2020
2024
Net profit margin
47.7%
This company
8.1%
Market median
+489% vs market
2020
2024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
2020
2024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RS
Ragnar Salmen
Chairman
2017
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Pharmore As
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Pharmore As
SVANELABORATORIET AS
(this company)
Board network connections
Board members of SVANELABORATORIET AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ragnar Salmen
Chairman
0 companies